GB201005822D0 - Use of iminosugars to enhance antibody-dependent cell-mediated cytotoxicity - Google Patents

Use of iminosugars to enhance antibody-dependent cell-mediated cytotoxicity

Info

Publication number
GB201005822D0
GB201005822D0 GBGB1005822.0A GB201005822A GB201005822D0 GB 201005822 D0 GB201005822 D0 GB 201005822D0 GB 201005822 A GB201005822 A GB 201005822A GB 201005822 D0 GB201005822 D0 GB 201005822D0
Authority
GB
United Kingdom
Prior art keywords
iminosugars
dependent cell
mediated cytotoxicity
enhance antibody
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1005822.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Summit Therapeutics Ltd
Original Assignee
Summit Corp PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Summit Corp PLC filed Critical Summit Corp PLC
Priority to GBGB1005822.0A priority Critical patent/GB201005822D0/en
Publication of GB201005822D0 publication Critical patent/GB201005822D0/en
Ceased legal-status Critical Current

Links

GBGB1005822.0A 2010-04-08 2010-04-08 Use of iminosugars to enhance antibody-dependent cell-mediated cytotoxicity Ceased GB201005822D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB1005822.0A GB201005822D0 (en) 2010-04-08 2010-04-08 Use of iminosugars to enhance antibody-dependent cell-mediated cytotoxicity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1005822.0A GB201005822D0 (en) 2010-04-08 2010-04-08 Use of iminosugars to enhance antibody-dependent cell-mediated cytotoxicity

Publications (1)

Publication Number Publication Date
GB201005822D0 true GB201005822D0 (en) 2010-05-26

Family

ID=42235976

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1005822.0A Ceased GB201005822D0 (en) 2010-04-08 2010-04-08 Use of iminosugars to enhance antibody-dependent cell-mediated cytotoxicity

Country Status (1)

Country Link
GB (1) GB201005822D0 (en)

Similar Documents

Publication Publication Date Title
HK1183802A1 (en) Therapeutic oral composition
IL233216A0 (en) Oral care compositions
ZA201306292B (en) Oral health improving compositions
HK1256896A1 (en) Methods and compositions to enable multiplex cold-pcr
EP2635254A4 (en) Compositions and methods relating to reduced mucoadhesion
SG11201401056SA (en) Oral care compositions
EP2509568A4 (en) Skin care compositions
LT2616064T (en) Ready to use ketorolac formulations
EP2659878A4 (en) Skin cleanser composition
PL3178472T3 (en) Oral formulations of methylnaltrexone
HK1203432A1 (en) Oral care compositions
HK1200345A1 (en) Compositions for skin exfoliation and use thereof
HK1203402A1 (en) Oral care compositions
EP2752186A4 (en) Skin cleanser composition
SG11201402840RA (en) Oral care compositions
HK1200705A1 (en) Oral care compositions
HK1203385A1 (en) Oral care compositions
EP2752185A4 (en) Skin cleanser composition
EP2552210A4 (en) Formulations of mazindol
ZA201304087B (en) Oral compositions
SI2407155T1 (en) Formulations of inecalcitol
HK1203386A1 (en) Oral care compositions
EP2640418A4 (en) Immunogenic compositions
GB201014317D0 (en) Preparation of electrode compositions
GB201005822D0 (en) Use of iminosugars to enhance antibody-dependent cell-mediated cytotoxicity

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)